Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HUM
HUM logo

HUM Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
309.240
Open
309.130
VWAP
305.89
Vol
1.57M
Mkt Cap
36.67B
Low
303.010
Amount
481.90M
EV/EBITDA(TTM)
11.03
Total Shares
120.06M
EV
45.78B
EV/OCF(TTM)
24.82
P/S(TTM)
0.27
Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.
Show More

Events Timeline

(ET)
2026-05-27
08:10:00
Humana Launches $83M Pharmacy Distribution Center in Orlando, Florida
select
2026-05-14 (ET)
2026-05-14
09:10:00
CVRx Secures Humana Medicare Coverage for Barostim Therapy
select

News

PRnewswire
7.0
05-30PRnewswire
Humana Faces Securities Class Action Investigation
  • Poor Financial Results: Humana reported a benefits expense ratio of approximately 91.4% for Q4 2023 and 88% for the full year, resulting in an adjusted EPS of only $26.09, which is over $2 less than previously predicted, indicating a significant decline in profitability.
  • Pessimistic Future Outlook: The company expects an adjusted EPS of only $16 for 2024, a $10 decrease from 2023, well below analysts' expectations of $29, reflecting ongoing pressures from rising medical costs.
  • Legal Proceedings Update: Humana and its executives are facing a securities class action lawsuit for failing to disclose material information, with the court partially denying the company's motion to dismiss, allowing the case to proceed, which could further impact the company's reputation and finances.
  • Investigation Focus: Kahn Swick & Foti is investigating whether Humana's executives breached their fiduciary duties to shareholders or violated laws, and if findings indicate wrongdoing, the company may face greater legal and financial risks.
CNBC
5.0
05-27CNBC
Amazon Health Executive Transition Announced
  • Executive Change: Neil Lindsay, Amazon's Senior Vice President of Health Services, will step down on July 1, with Dr. Roy Schoenberg, co-founder of telemedicine company Amwell, taking over; Lindsay will remain as an advisor until year-end to ensure a smooth transition.
  • Strategic Focus: Following its 2018 acquisition of PillPack, Amazon has aimed to penetrate the complex U.S. healthcare market, enhancing its capabilities with the $3.9 billion acquisition of One Medical in 2023, which provides access to physical clinics and a robust membership base.
  • Technological Innovation: Earlier this year, Amazon launched an AI health tool capable of analyzing medical records, booking appointments, and answering queries, demonstrating its ongoing commitment to investment and innovation in healthcare technology.
  • Leadership Restructuring: This transition marks the latest executive shakeup in Amazon's healthcare unit, reflecting the company's strategic reorganization in the medical sector, aimed at driving future growth by introducing leaders with deeper healthcare expertise.
NASDAQ.COM
4.5
05-26NASDAQ.COM
US Stocks Close Higher: S&P 500 Hits All-Time High
  • Market Performance: The S&P 500 rose by 0.61% and the Nasdaq 100 increased by 1.76%, reaching all-time highs, indicating strong demand for tech stocks amid falling oil prices and progress in US-Iran peace talks.
  • Oil Price Volatility: WTI crude oil prices fell to a 2.5-week low as US-Iran negotiations aimed at reopening the Strait of Hormuz progressed, although military actions by US Central Command pressured market sentiment, leading to declines in energy stocks.
  • Economic Data Impact: The Chicago Fed National Activity Index rose to a 13-month high of 0.14, surpassing expectations, while a slight decline in the consumer confidence index reflects the complexities of economic recovery, potentially influencing future market trends.
  • Earnings Reports: As of Tuesday, 83% of the 475 S&P 500 companies reported earnings above expectations, with Q1 earnings projected to grow by 12% year-on-year, although excluding the tech sector, the increase is only 3%, highlighting disparities across industries.
NASDAQ.COM
4.5
05-26NASDAQ.COM
US Stock Indices Rally, Led by Technology Stocks
  • Strong Market Performance: The S&P 500 Index rose by 0.81% and the Nasdaq 100 Index increased by 1.74%, reaching all-time highs, indicating robust market support for technology stocks, particularly amid falling crude oil prices and declining bond yields.
  • Mixed Economic Data: The Chicago Fed National Activity Index rose to a 13-month high of 0.14, surpassing expectations, while the S&P Composite-20 home price index increased by only 0.83% year-on-year, below the expected 0.90%, suggesting weakness in the housing market that could impact future consumer confidence.
  • Volatile Oil Market: WTI crude oil prices fell to a 2.5-week low due to progress in US-Iran peace talks, although US Central Command's strikes on Iranian targets caused market fluctuations, highlighting the ongoing geopolitical influence on energy markets.
  • Earnings Season Insights: So far, 83% of the 475 S&P 500 companies have beaten earnings estimates, with Q1 earnings projected to rise by 12% year-on-year; however, excluding the technology sector, the increase is only 3%, reflecting pressure on overall economic growth.
CNBC
6.0
05-20CNBC
Latest Wall Street Rating Updates
  • Goldman Sachs Reiterates Buy on Broadcom: Goldman raised Broadcom's price target from $480 to $500, anticipating strong CapEx spending patterns from key customers, indicating that the upcoming earnings report may exceed market expectations.
  • Oppenheimer Upgrades Rubrik: Oppenheimer upgraded Rubrik from Perform to Outperform with a price target of $85, based on strong checks from value-added resellers, highlighting the product's competitive strength in the market.
  • UBS Upgrades Packaging Corp: UBS upgraded Packaging Corp from Neutral to Buy, expecting the $50/ton price hike to stick, which, combined with high utilization and prior capacity cuts, could add approximately $290 million in annualized EBITDA.
  • Deutsche Bank Upgrades Humana: Deutsche Bank believes there is still time to buy shares of Humana, upgrading its rating to Buy, as it anticipates a new rally in managed care organizations that is just beginning.
CNBC
9.5
05-20CNBC
Market Dynamics and Earnings Preview Ahead
  • Market Outlook: U.S. stock futures rise ahead of Nvidia's earnings report, breaking a three-day losing streak for the S&P 500, as President Trump hints at a quick end to the Iran war, leading to slight declines in oil prices and interest rates, which boosts market sentiment.
  • Nvidia Earnings Anticipation: Nvidia is set to release its earnings tonight, with market expectations for a beat to drive a post-earnings rally; however, skepticism remains regarding its ability to maintain market share amidst competition from Amazon and Google’s in-house chips.
  • Target's Performance Rebound: Under new CEO leadership, Target reported a quarterly earnings beat with same-store sales up 5.6%, significantly surpassing the 2.4% consensus, and raised its full-year net sales growth forecast to 4%, indicating strong growth in fashion and health products.
  • UnitedHealth Stock Recovery: UnitedHealth has shown strong performance since CEO Steve Hemsley's return, with Mizuho raising its price target from $410 to $440, reflecting a 20% stock price increase over the past month, indicating market confidence in its growth trajectory.
Wall Street analysts forecast HUM stock price to rise
19 Analyst Rating
Wall Street analysts forecast HUM stock price to rise
6 Buy
12 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
231.00
Averages
290.39
High
344.00
Current: 0.000
sliders
Low
231.00
Averages
290.39
High
344.00
Barclays
Equal Weight
maintain
$180 -> $344
AI Analysis
2026-05-26
Reason
Barclays
Price Target
$180 -> $344
AI Analysis
2026-05-26
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Humana to $344 from $180 and keeps an Equal Weight rating on the shares. The firm believes the managed care stock moves post the Q1 reports are "durable." It continues to prefer managed care over facilities, saying inflation and commercial mix represent increasing drivers of provider earnings risk. Barclays adjusted ratings and targets in the group.
Deutsche Bank
Hold
to
Buy
upgrade
$235 -> $441
2026-05-20
Reason
Deutsche Bank
Price Target
$235 -> $441
2026-05-20
upgrade
Hold
to
Buy
Reason
As previously reported, Deutsche Bank upgraded Humana to Buy from Hold with a price target of $441, up from $235. The firm upgraded three managed care names citing a stabilizing managed care market. For Humana, the analyst expects the company's Medicare star ratings to recover. 2026 should be the earnings bottom for Humana and a rebasing year depending on stars results in October, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HUM
Unlock Now

Valuation Metrics

The current forward P/E ratio for Humana Inc (HUM.N) is 33.67, compared to its 5-year average forward P/E of 18.92. For a more detailed relative valuation and DCF analysis to assess Humana Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
18.92
Current PE
33.67
Overvalued PE
21.88
Undervalued PE
15.96

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
11.09
Current EV/EBITDA
5.22
Overvalued EV/EBITDA
14.93
Undervalued EV/EBITDA
7.26

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.44
Current PS
0.22
Overvalued PS
0.62
Undervalued PS
0.27

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

which stocks to buy short term
Intellectia · 40 candidates
Moving Average Relationship: PriceAboveMA20Week Price Change Pct: $4.00 - $12.00Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
ELV logo
ELV
Elevance Health Inc
74.87B
QCOM logo
QCOM
Qualcomm Inc
158.82B
VTR logo
VTR
Ventas Inc
39.76B
KDP logo
KDP
Keurig Dr Pepper Inc
39.76B
PKG logo
PKG
Packaging Corp of America
18.95B
BKR logo
BKR
Baker Hughes Co
68.37B
today's stock picks
Intellectia · 74 candidates
Volume: >= 1,000,000Price Change Pct: $1.00 - $10.00List Exchange: XNYS, XNASMoving Average Relationship: PriceAboveMA20Is Index Component: GSPC, NDX
Ticker
Name
Market Cap$
top bottom
KO logo
KO
Coca-Cola Co
329.83B
NUE logo
NUE
Nucor Corp
48.80B
MOH logo
MOH
Molina Healthcare Inc
9.17B
BEN logo
BEN
Franklin Resources Inc
14.12B
UDR logo
UDR
UDR Inc
11.42B
AVB logo
AVB
AvalonBay Communities Inc
23.98B
looking for swing trade stocks today
Intellectia · 71 candidates
Relative Vol: >= 1.80List Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20Week Price Change Pct: $5.00 - $20.00Is Index Component: GSPCMonthly Average Dollar Volume: >= 3,000,000
Ticker
Name
Market Cap$
top bottom
ON logo
ON
ON Semiconductor Corp
33.65B
DELL logo
DELL
Dell Technologies Inc
131.89B
HPE logo
HPE
Hewlett Packard Enterprise Co
36.90B
BBWI logo
BBWI
Bath & Body Works Inc
4.20B
DHI logo
DHI
D.R. Horton Inc
44.42B
SWK logo
SWK
Stanley Black & Decker Inc
11.67B
most profit stock on Wednesday
Intellectia · 2823 candidates
Market Cap: >= 300.00MRegion: USPrice: >= $1.00List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
MOVE logo
MOVE
Corvex, Inc
809.51M
CAR logo
CAR
Avis Budget Group Inc
9.01B
ALHC logo
ALHC
Alignment Healthcare Inc
4.43B
ACIU logo
ACIU
AC Immune SA
316.52M
ARMP logo
ARMP
Armata Pharmaceuticals Inc
437.76M
OVID logo
OVID
Ovid Therapeutics Inc
386.63M
stock of the day
Intellectia · 13 candidates
Market Cap: >= 5.00BPrice Change Pct: >= $3.00Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA20Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
CAR logo
CAR
Avis Budget Group Inc
6.73B
SSL logo
SSL
Sasol Ltd
7.96B
UNH logo
UNH
UnitedHealth Group Inc
255.38B
PSKY logo
PSKY
Paramount Skydance Corp
10.95B
HUM logo
HUM
Humana Inc
21.93B
AAOI logo
AAOI
Applied Optoelectronics Inc
8.35B
stock bearish today
Intellectia · 57 candidates
Market Cap: >= 2.00BPrice Change Pct: <= $-3.00Moving Average Relationship: PriceBelowMA20, PriceBelowMA200
Ticker
Name
Market Cap$
top bottom
BMI logo
BMI
Badger Meter Inc
4.89B
CVNA logo
CVNA
Carvana Co
104.69B
APH logo
APH
Amphenol Corp
198.88B
TLK logo
TLK
Telkom Indonesia (Persero) Tbk PT
23.13B
LPL logo
LPL
LG Display Co Ltd
4.36B
VFC logo
VFC
VF Corp
7.85B
find me stock that have found their bottom
Intellectia · 25 candidates
Weekly Average Turnover: >= 1,000,000Rsi 14: <= 70Moving Average Relationship: PriceCrossAboveMA20Support Resistance Relationship: PriceAroundSupport
Ticker
Name
Market Cap$
top bottom
SCHW logo
SCHW
Charles Schwab Corp
180.87B
UBS logo
UBS
UBS Group AG
148.23B
BCS logo
BCS
Barclays PLC
89.27B
ING logo
ING
ING Groep NV
83.26B
NSC logo
NSC
Norfolk Southern Corp
64.87B
MFC logo
MFC
Manulife Financial Corp
62.58B
stocks with wolfe wave buy signals
Intellectia · 43 candidates
Relative Vol: >= 0.800Rsi 14: 40 - 70Moving Average Relationship: PriceAboveMA20Candlestick Pattern: WhiteCandlestickSupport Resistance Relationship: PriceAroundSupport
Ticker
Name
Market Cap$
top bottom
SCHW logo
SCHW
Charles Schwab Corp
180.87B
UBS logo
UBS
UBS Group AG
148.23B
BCS logo
BCS
Barclays PLC
89.27B
ING logo
ING
ING Groep NV
83.26B
NSC logo
NSC
Norfolk Southern Corp
64.87B
MFC logo
MFC
Manulife Financial Corp
62.58B
suche andere Möglichkeiten bzw. Aktien
Intellectia · 25 candidates
Beta: LowRiskAnalyst Action: UpgradeTarget Price Upside Potential: AbovePriceMonth Price Change Pct: >= $5.00Is Index Component: GSPC
Ticker
Name
Market Cap$
top bottom
CVX logo
CVX
Chevron Corp
335.71B
MRK logo
MRK
Merck & Co Inc
275.78B
TMO logo
TMO
Thermo Fisher Scientific Inc
239.06B
BA logo
BA
Boeing Co
190.08B
HON logo
HON
Honeywell International Inc
139.15B
GD logo
GD
General Dynamics Corp
98.53B
show me stocks with a bullish reversal
Intellectia · 131 candidates
Relative Vol: >= 1.20Rsi 14: 30 - 60Moving Average Relationship: PriceCrossAboveMA20Candlestick Pattern: WhiteCandlestickMonth Price Change Pct: >= $0.00
Ticker
Name
Market Cap$
top bottom
GOOG logo
GOOG
Alphabet Inc
3.96T
LLY logo
LLY
Eli Lilly and Co
1.02T
SCHW logo
SCHW
Charles Schwab Corp
180.87B
BTI logo
BTI
British American Tobacco plc
125.29B
ARM logo
ARM
Arm Holdings PLC
120.87B
COP logo
COP
ConocoPhillips
120.05B

Whales Holding HUM

M
Maple Rock Capital Partners Inc.
Holding
HUM
+34.56%
3M Return
S
Slate Path Capital LP
Holding
HUM
+34.31%
3M Return
T
Tontine Management, LLC
Holding
HUM
+33.83%
3M Return
W
Wolverine Trading, LLC
Holding
HUM
+29.42%
3M Return
O
Osmosis Investment Management UK Limited
Holding
HUM
+19.56%
3M Return
G
Group One Trading LLC
Holding
HUM
+17.13%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Humana Inc (HUM) stock price today?

The current price of HUM is 305.42 USD — it has decreased -1.06

What is Humana Inc (HUM)'s business?

Humana Inc. provides Humana insurance services and CenterWell health care services. The Company's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.

What is the price predicton of HUM Stock?

Wall Street analysts forecast HUM stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HUM is290.39 USD with a low forecast of 231.00 USD and a high forecast of 344.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Humana Inc (HUM)'s revenue for the last quarter?

Humana Inc revenue for the last quarter amounts to 39.65B USD, increased 23.47

What is Humana Inc (HUM)'s earnings per share (EPS) for the last quarter?

Humana Inc. EPS for the last quarter amounts to 9.83 USD, decreased -4.47

How many employees does Humana Inc (HUM). have?

Humana Inc (HUM) has 67060 emplpoyees as of June 01 2026.

What is Humana Inc (HUM) market cap?

Today HUM has the market capitalization of 36.67B USD.